United Therapeutics Corporation shares owned by BlackRock
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.7B | 5.5M | 318.55 |
| 2024-03-31 | $1.3B | 5.6M | 229.72 |
| 2023-09-30 | $1.2B | 5.1M | 225.87 |
| 2023-06-30 | $1.1B | 5.1M | 220.75 |
| 2023-03-31 | $1.1B | 4.8M | 223.96 |
| 2022-12-31 | $1.3B | 4.5M | 278.09 |
| 2022-06-30 | $1.0B | 4.3M | 235.64 |
| 2021-06-30 | $777M | 4.3M | 179.41 |
| 2021-03-31 | $738M | 4.4M | 167.27 |
| 2020-12-31 | $649M | 4.3M | 151.79 |
| 2020-09-30 | $435M | 4.3M | 101.00 |
| 2020-03-31 | $423M | 4.5M | 94.83 |
| 2019-12-31 | $409M | 4.6M | 88.08 |
| 2019-09-30 | $353M | 4.4M | 79.75 |
| 2019-06-30 | $351M | 4.5M | 78.06 |
| 2019-03-31 | $586M | 5.0M | 117.37 |
| 2018-12-31 | $538M | 4.9M | 108.90 |
| 2018-09-30 | $630M | 4.9M | 127.88 |
| 2018-06-30 | $569M | 5.0M | 113.15 |
| 2018-03-31 | $552M | 4.9M | 112.36 |
| 2017-09-30 | $563M | 4.8M | 117.18 |
| 2016-12-31 | $16M | 110k | 143.43 |
| 2016-09-30 | $15M | 125k | 118.07 |
| 2016-06-30 | $14M | 129k | 105.91 |
| 2016-03-31 | $17M | 150k | 111.43 |
| 2015-12-31 | $30M | 192k | 156.61 |
| 2015-09-30 | $16M | 120k | 131.24 |
| 2015-06-30 | $20M | 112k | 173.95 |
| 2015-03-31 | $36M | 206k | 172.43 |
| 2014-12-31 | $25M | 192k | 129.49 |
| 2014-09-30 | $19M | 148k | 128.65 |
| 2014-06-30 | $18M | 200k | 88.49 |
| 2014-03-31 | $23M | 242k | 94.03 |
| 2013-12-31 | $27M | 236k | 113.08 |
| 2013-09-30 | $12M | 149k | 78.85 |
| 2013-06-30 | $9.2M | 140k | 65.82 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation